Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Physiological effects of a spit sock.

Lutz M, Sloane CM, Castillo EM, Brennen JJ, Coyne CJ, Swift SL, Vilke GM.

Am J Emerg Med. 2018 Oct 3. pii: S0735-6757(18)30806-4. doi: 10.1016/j.ajem.2018.09.050. [Epub ahead of print]

PMID:
30415982
2.

Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.

Balathasan L, Tang VA, Yadollahi B, Brun J, Labelle M, Lefebvre C, Swift SL, Stojdl DF.

Mol Ther Oncolytics. 2017 Sep 15;7:45-56. doi: 10.1016/j.omto.2017.09.004. eCollection 2017 Dec 15.

3.

Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.

Bramlage P, Swift SL, Thoenes M, Minguet J, Ferrero C, Schmieder RE.

Eur J Heart Fail. 2017 Jun;19(6):811. doi: 10.1002/ejhf.888. No abstract available.

4.

High-throughput screening to enhance oncolytic virus immunotherapy.

Allan KJ, Stojdl DF, Swift SL.

Oncolytic Virother. 2016 Apr 5;5:15-25. doi: 10.2147/OV.S66217. eCollection 2016. Review.

5.

Correction: Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway.

Anipindi VC, Bagri P, Roth K, Dizzell SE, Nguyen PV, Shaler CR, Chu DK, Jiménez-Saiz R, Liang H, Swift SL, Nazli A, Kafka JK, Bramson J, Xing Z, Jordana M, Wan Y, Snider DP, Stampfli MR, Kaushic C.

PLoS Pathog. 2016 Jun 8;12(6):e1005706. doi: 10.1371/journal.ppat.1005706. eCollection 2016 Jun.

6.

Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination.

Bridle BW, Nguyen A, Salem O, Zhang L, Koshy S, Clouthier D, Chen L, Pol J, Swift SL, Bowdish DM, Lichty BD, Bramson JL, Wan Y.

J Immunol. 2016 Jun 1;196(11):4587-95. doi: 10.4049/jimmunol.1600106. Epub 2016 Apr 27.

7.

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy.

Swift SL, Stojdl DF.

Viruses. 2016 Feb 5;8(2). pii: E45. doi: 10.3390/v8020045. Review.

8.

Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.

Bramlage P, Swift SL, Thoenes M, Minguet J, Ferrero C, Schmieder RE.

Eur J Heart Fail. 2016 Jan;18(1):28-37. doi: 10.1002/ejhf.444. Epub 2015 Dec 3. Review. Erratum in: Eur J Heart Fail. 2017 Jun;19(6):811.

9.

From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer.

Ilkow CS, Swift SL, Bell JC, Diallo JS.

PLoS Pathog. 2014 Jan;10(1):e1003836. doi: 10.1371/journal.ppat.1003836. Epub 2014 Jan 16. Review.

10.

Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor.

McGray AJ, Hallett R, Bernard D, Swift SL, Zhu Z, Teoderascu F, Vanseggelen H, Hassell JA, Hurwitz AA, Wan Y, Bramson JL.

Mol Ther. 2014 Jan;22(1):206-18. doi: 10.1038/mt.2013.255. Epub 2013 Oct 23.

11.

Evaluating baculovirus as a vector for human prostate cancer gene therapy.

Swift SL, Rivera GC, Dussupt V, Leadley RM, Hudson LC, Ma de Ridder C, Kraaij R, Burns JE, Maitland NJ, Georgopoulos LJ.

PLoS One. 2013 Jun 6;8(6):e65557. doi: 10.1371/journal.pone.0065557. Print 2013.

12.

Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines.

Bassett JD, Swift SL, VanSeggelen H, Hammill JA, McGray AJ, Evelegh C, Wan Y, Bramson JL.

Mol Ther. 2012 Apr;20(4):860-9. doi: 10.1038/mt.2011.281. Epub 2011 Dec 20.

13.

Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.

Bassett JD, Swift SL, Bramson JL.

Expert Rev Vaccines. 2011 Sep;10(9):1307-19. doi: 10.1586/erv.11.88. Review.

PMID:
21919620
14.

Baculoviruses as gene therapy vectors for human prostate cancer.

Rivera-Gonzalez GC, Swift SL, Dussupt V, Georgopoulos LJ, Maitland NJ.

J Invertebr Pathol. 2011 Jul;107 Suppl:S59-70. doi: 10.1016/j.jip.2011.05.006. Review.

PMID:
21784232
15.

CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.

Bassett JD, Yang TC, Bernard D, Millar JB, Swift SL, McGray AJ, VanSeggelen H, Boudreau JE, Finn JD, Parsons R, Evelegh C, Damjanovic D, Grinshtein N, Divangahi M, Zhang L, Xing Z, Wan Y, Bramson JL.

Blood. 2011 Jan 27;117(4):1146-55. doi: 10.1182/blood-2010-03-272336. Epub 2010 Nov 18.

16.

Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer.

Swift SL, Burns JE, Maitland NJ.

Cancer Res. 2010 Jan 1;70(1):347-56. doi: 10.1158/0008-5472.CAN-09-1252.

Supplemental Content

Loading ...
Support Center